MRI-guided high-dose radiation for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new way to give high-dose radiation to prostate cancer while using an MRI to precisely target the tumor. It is for early-stage prostate cancer, and aims to reduce side effects by treating only the cancer, not the whole prostate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be in generally good health (able to handle daily activities, with minimal or no assistance).
- You must have low-risk or intermediate-risk prostate cancer, as determined by your PSA, Gleason score, and tumor stage.
- You must have a visible lesion on a special MRI of the prostate (called multiparametric MRI), with a PI-RADS score of 3 or higher.
- A prostate biopsy must confirm that the cancer is only on one side of the prostate and matches the MRI findings.
- You must not have had prior radiation to the prostate, prior focal therapy (like HIFU or cryotherapy), or certain other prostate procedures that might interfere with treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise radiation technique that adapts to your body's daily changes. It may offer better outcomes for men with prostate cancer that hasn't spread outside the pelvic area.
This trial compares two imaging methods (CT and MRI) used to plan a type of radiation therapy for prostate cancer called high-dose-rate brachytherapy. The goal is to see if one method provides better targeting of the cancer while sparing healthy tissue.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
This trial tests a short, high-dose radiation treatment for early-stage prostate cancer. It uses MRI to guide the treatment precisely, which may reduce side effects and shorten treatment time.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This study tests radiation treatment planned and guided using MRI scans (“image-guided radiotherapy”) for men with prostate cancer who are aiming for a cure. If you qualify, you may receive radiation with more precise targeting using MRI to help deliver treatment accurately.
Hear when a new Stage I Prostate Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.